Testing DNA Could be the way Forward for Predicting Responses to Cancer Therapies
Performance of EGFR Mutation Test Kit creates scope for blood-based prediction of drug response in lung cancer.
Independent Forensics Releases Test to Measure Human Genetic Resistance to HIV
The test can determine if a person is a fast, neutral or slow progressor to AIDS after HIV infection.
Gene Variation Affects Asthma Drug Treatment
Researchers found that a specific genetic variant, known as the Arg/Arg-16 variant, causes salmeterol to be ineffective.
Meeting Held to Evaluate Colon Cancer Screening Guidelines
Among other topics, the potential inclusion of stool-based DNA testing among the current colon cancer screening guidelines recommendations were discussed.
LabCorp® and Duke University Collaborate to Offer Genomic Tests
The program will support advanced research studies in specified clinical testing applications in genomic medicine.
Clinical Data Announces Launch of Genetic Test for Warfarin Response
Company licenses intellectual property relating to genetic testing for warfarin response.
OHSU Cancer Institute Study Points to Future of Personalized Medicine
Scientists discover that patients responded differently to the targeted therapy Sunitinib depending on the type of genetic abnormality in their cancer.
Researchers Present Advances in Prostate Cancer Program
Markers discovered that may aid in the prediction of recurrence of prostate cancer.
Personalized Treatment Trial for Breast Cancer Launched
This trial is important because it is one of the first to examine a methodology for personalizing cancer treatment.
FDA Grants Biovest International Fast Track Status for BiovaxID™
Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.